(TX_NEW) Number of adults and children newly enrolled on antiretroviral therapy (ART)

Export Indicator

Number of adults and children newly enrolled on antiretroviral therapy (ART)
What it measures

The indicator measures the ongoing scale-up and uptake of ART programs. This measure is critical to monitor along with number of patients currently on ART in relation to the number of PLHIV that are estimated to be eligible for treatment to assess progress in the program’s response to the epidemic in specific geographic areas and populations as well as at the national level. This is particularly critical in the context of current revisions to country-specific ART eligibility. Reporting the number of new patients enrolled on ART at both the national and overall PEPFAR program levels is critical to monitoring the HIV services cascade, specifically the successful linkage between HIV diagnosis and initiating ART. Disaggregation of new on ART by age/sex at ART initiation, pregnancy status at ART initiation, and breastfeeding status at ART initiation is important to understand the percentage of new ART initiations coming from priority populations.


Number of adults and children newly enrolled on antiretroviral therapy (ART)




Sum across all reporting periods.

Method of measurement

Facility ART registers/databases, program monitoring tools, or drug supply management systems.

· The numerator can be generated by counting the number of adults and children who are newly enrolled in ART in the reporting period, in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards).

· Patients who known to transfer in from another facilities, or who temporarily stopped therapy and have started again should not be counted as new patients.

· NEW is a state defined by an individual initiating ART during the reporting period. It is expected that the characteristics of new clients are recorded at the time they newly initiate life-long ART. For example patients who receive post-exposure prophylaxis (PEP), short term ART only for prevention (PREP), or ART starter pack alone should not be used to count individuals reached with this indicator.

TB/ HIV disaggregation: At initiation of ART, number of patients with a confirmed diagnoses of TB (new and relapsed) and/or on TB treatment collected from TB/HIV registers;

Key population disaggregation* see Appendix 1 to support the identification of key populations at ART initiation; If a patient identifies as more than one of the KPs, please enter in all of those that are relevant (therefore KP disaggregations can equal more than the total);

NOTE: both KP-specific and clinical partners have the option to complete these disagg, but only if safe to maintain these files and to report.

How to review for data quality:

Confirm that TX_CURR ≥ TX_NEW

 Only one age disaggregation type is used for age/sex:

- The number of individuals newly receiving ART must be disaggregated by age and sex. If possible, the full age/sex disaggregations should be used. If the full age/sex disaggregations are not possible, then, and only then, should the aggregated age/sex disaggregations be used, do NOT complete both age/sex disaggregations.

 Numerator ≥ subtotal of each disaggregation

- The total number of adults and children newly enrolled on ART should be greater or equal to the sum of all of the age/sex disaggregations and pregnancy/ breastfeeding status

Reporting Level

Site level, facility only

Measurement frequency

Report 3 months of results for these indicators at each quarterly reporting cycle.


Numerator: Number of adults and children newly enrolled on antiretroviral therapy (ART)

Age/Sex (Fine Disaggregate) (Required)

<1, 1-9, 10- 14 M, 10-14 F, 15-19 M, 15-19 F, 20- 24 M, 20-24 F, 25-49 M, 25-49 F, 50+ M, 50+ F

Age/Sex (Course Coarse Disaggregate) (Conditional)

<1, <15 M, <15 F, 15+ M, 15+ F

TB/HIV status (Required)

TB/HIV status

Pregnancy and breastfeeding status (Required)

Pregnant at initiation of ART; Breastfeeding at initiation of ART

Key population (Optional)

MSM, Transgender, SW, PWID, People in prisons or other enclosed settings

Description of Disaggregate

Age is defined as the age of the patient at the date of initiation on ART, not the age at the date of reporting

This disaggregation should only be entered if finer age disaggregates are not available.

At initiation of ART, number of patients with a confirmed diagnoses of TB (new and relapsed) and/or on TB treatment

Pregnancy and Breastfeeding status is defined as the status at the date of initiation on ART, not the status at the date of reporting.

At the time of HIV testing, did the patient identify as one of the following key populations:

MSM: Men who have sex with men. A male that has sex with men or both and women

TG: Person who identifies as transgender. Transgender (male to) female: individual was born a boy, but identifies as a woman: Transgender (female to) male: client was born a girl, but identifies as a man

SW: Sex worker. A person whose main source (includes both monetary and non-monetary) of income comes from sex work.

PWID: People who inject drugs. Any person who has injected illicit or illegal drugs in the last 6 months. Person in prisons or other enclosed setting. If client is currently incarcerated, then classify as Person in prison or other enclosed setting.

Denominator: N/A

Disaggregate Groups: N/A

Disaggregates: N/A

Description of Disaggregate: N/A

Further information

MER 1.0 to 2.0 Change

Age/Sex disaggregates aligned across clinical cascade; TB disaggregate added to the indicator Key population added to the indicator.

PEPFAR Support definition

Standard definition of DSD and TA-SDI used

Provision of key staff or commodities for PLHIV receiving ART include: the provision of key staff and/or commodities can include ongoing procurement of critical commodities, such as ARVs, or funding for salaries of HCW who deliver HIV treatment services. Staff who are responsible for the completeness and quality of routine patient records (paper or electronic) can be counted here; however, staff who exclusively fulfill MOH and donor reporting requirements cannot be counted.

Ongoing support for PLHIV receiving ART service delivery improvement includes: clinical mentoring and supportive supervision of staff at HIV sites providing ART, support for quality improvement activities, patient tracking system support, routine support of ART M&E and reporting, commodities consumption forecasting and supply management.

DREAMS SNU Specific Guidance